Patent ID: 7101711
Filing Date: 2006-09-05
Classification: A61K,A61P,C07F,C07H,C12N

Abstract:
1. A method for activating a Tγ9δ2 lymphocyte in vitro, comprising: contacting in vitro a Tγ9δ2 lymphocyte with an effective amount of a compound comprising at least one phosphoepoxide group, said compound having a formula selected from the group consisting of (a) a compound having the following formula: wherein R1 is selected from among —CH 3 and —CH 2 CH 3 , Cat n is an integer between 2 and 20; (b) a compound having the following formula: wherein R1 is selected from among —CH 3 and —CH 2 CH 3 , Cat n is an integer between 2 and 20; and (c) a compound having the following formula: wherein R1 is selected from among —CH 3 and CH 2 CH 3 , Cat n is an integer between 2 and 20, and R2 is a biomolecule.